anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.10.18 | Roche Hold | Deutsche Bank AG | |
| 18.10.18 | Novartis buy | Jefferies & Company Inc. | |
| 18.10.18 | Roche buy | Baader Bank | |
| 18.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.10.18 | Novartis buy | Baader Bank | |
| 18.10.18 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.10.18 | Roche Underperform | Credit Suisse Group | |
| 17.10.18 | Roche Neutral | UBS AG | |
| 17.10.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 17.10.18 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.10.18 | Roche buy | Baader Bank | |
| 17.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 17.10.18 | Roche buy | Jefferies & Company Inc. | |
| 17.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 12.10.18 | Novartis buy | Baader Bank | |
| 11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.10.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.10.18 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 10.10.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 03.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 02.10.18 | Roche overweight | JP Morgan Chase & Co. | |
| 28.09.18 | Roche Hold | Deutsche Bank AG | |
| 28.09.18 | Novartis Hold | Deutsche Bank AG | |
| 25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
| 25.09.18 | Novartis Neutral | UBS AG | |
| 25.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
| 20.09.18 | Novartis Equal weight | Barclays Capital | |
| 19.09.18 | Roche Neutral | UBS AG | |
| 14.09.18 | Roche Neutral | UBS AG | |
| 14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.09.18 | Novartis buy | Citigroup Corp. | |
| 11.09.18 | Novartis Neutral | UBS AG | |
| 11.09.18 | Roche Underperform | BNP PARIBAS | |
| 11.09.18 | Novartis Neutral | BNP PARIBAS | |
| 10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
| 10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. |
